Global Infectious Diseases Partnering Report 2022: Access
Dublin, Oct. 19, 2022 (GLOBE NEWSWIRE) -- The "Global Infectious Diseases Partnering 2015-2022: Deal trends, players and financials" report has been...
Stay updated with breaking news from Groupb Streptococcus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Oct. 19, 2022 (GLOBE NEWSWIRE) -- The "Global Infectious Diseases Partnering 2015-2022: Deal trends, players and financials" report has been...
A recurrent urinary tract infection (UTI) is a common debilitating condition whereby uropathogens are able to survive within the urinary tract. In this study, we aimed to determine if the common uropathogens Escherichia coli, Enterococcus faecalis, and Group B Streptococcus possessed virulence mechanisms that enable the invasion of urothelial cells. Urothelial cells were isolated from women with detrusor overactivity and recurrent UTIs; the intracellular localisation of the uropathogens was determined by confocal microscopy. Uropathogens were also isolated from women with acute UTIs and their ...
The FDA has granted Breakthrough Therapy designation to an investigational Group B Streptococcus vaccine candidate to prevent invasive GBS disease.
The FDA has granted Breakthrough Therapy designation to an investigational Group B Streptococcus vaccine candidate to prevent invasive GBS disease.
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) on Wednesday said its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 received Breakthrough Therapy Designation from the Food and